Bigsby Robert M, Valluri Shailaja, Lopez Jennifer, Mendonca Marc S, Caperell-Grant Andrea, DesRosiers Colleen, Dynlacht Joseph R
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3304-10. doi: 10.1167/iovs.08-3262. Epub 2009 Feb 28.
Epidemiologic data on the effects of female sex hormones in cataract formation are conflicting. With the use of a rat model of radiation-induced cataractogenesis, it was found that estrogen can either enhance or inhibit the progression of radiation cataracts, depending on when the hormone is administered. The present study was performed to further define radiation-hormone interactions during cataractogenesis.
In one experiment, rats were left ovary-intact or ovariectomized and were then irradiated with 2.5, 5, 10, or 15 Gy to one eye. In another experiment, ovariectomized rats were treated continuously with three different doses of estradiol through a slow-release capsule implanted subcutaneously, after which one eye was irradiated with 15 Gy. In all animals, cataract formation was followed by slit lamp examination at regular intervals.
Latency to identification of cataracts decreased exponentially with increasing radiation dose. The presence of ovaries enhanced cataractogenesis when the eye was irradiated with 15 Gy, but there was no difference between ovary-intact and ovariectomized rats that were irradiated at lower doses. In ovariectomized rats irradiated with 15 Gy, estradiol increased the rate of progression of cataracts in a dose-dependent manner. The rate of cataract progression increased linearly with increasing estradiol dose; there was no sign of saturation at high estradiol doses, as would be expected from a receptor-mediated effect.
Ovarian hormones enhance radiation-induced cataract formation; hormone supplementation experiments indicate that estrogen is responsible for this effect. The data suggest that the enhancing effect of estradiol is not mediated by its receptor, but this requires further study.
关于女性性激素在白内障形成过程中作用的流行病学数据相互矛盾。通过使用辐射诱导白内障形成的大鼠模型,发现雌激素对辐射性白内障进展的影响取决于激素给药时间,既可以增强也可以抑制其进展。本研究旨在进一步明确白内障形成过程中辐射与激素的相互作用。
在一项实验中,将大鼠保留完整卵巢或进行卵巢切除,然后对一只眼睛给予2.5、5、10或15 Gy的辐射。在另一项实验中,对卵巢切除的大鼠通过皮下植入缓释胶囊连续给予三种不同剂量的雌二醇,之后对一只眼睛给予15 Gy的辐射。在所有动物中,定期通过裂隙灯检查观察白内障的形成情况。
白内障识别的潜伏期随辐射剂量增加呈指数下降。当眼睛接受15 Gy辐射时,卵巢的存在会增强白内障的形成,但在较低剂量辐射的完整卵巢大鼠和卵巢切除大鼠之间没有差异。在接受15 Gy辐射的卵巢切除大鼠中,雌二醇以剂量依赖的方式增加白内障的进展速度。白内障进展速度随雌二醇剂量增加呈线性增加;在高剂量雌二醇时没有饱和迹象,而这是受体介导效应所预期的。
卵巢激素会增强辐射诱导的白内障形成;激素补充实验表明雌激素是造成这种效应的原因。数据表明雌二醇的增强作用不是由其受体介导的,但这需要进一步研究。